Related Experiment Video
Updated: May 28, 2026
07:39
The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Cell lineage specification in tumor progression and metastasis
Paul D Cao1, William K C Cheung, Don X Nguyen
1Brady Memorial Laboratory, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Discovery Medicine
|October 28, 2011
Summary
Cancer metastasis is influenced by tumor cell developmental lineage. Understanding how developmental programs are subverted in cancer offers new therapeutic opportunities and biological insights.
Area of Science:
- Oncology
- Developmental Biology
- Cell Biology
Background:
- Historical perspectives link cancer to embryonal cell origins.
- Contemporary views posit tumors arise from somatic tissues.
- Numerous examples connect cancer biology to normal and aberrant developmental processes.
Purpose of the Study:
- To review how the developmental lineage of tumor cells impacts cancer metastasis.
- To explore the subversion of developmental programs in human diseases.
Main Methods:
- Literature review of developmental biology and cancer research.
- Analysis of molecular mechanisms controlling cell fate.
- Synthesis of findings on developmental lineage and metastasis.
Main Results:
- Developmental lineage is a key factor in cancer metastasis.
- Subversion of normal developmental pathways contributes to cancer progression.
- Uncovering molecular mechanisms provides new therapeutic targets.
Conclusions:
- Understanding developmental lineage in cancer is crucial for fundamental biological discovery.
- Targeting subverted developmental programs presents novel therapeutic opportunities for cancer treatment.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:30Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
01:21Lineage Commitment
Commitment is the process whereby stem cells:
02:40Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...